Serum matrix metalloproteinase 7 (MMP7) is a biomarker of fibrosis in patients with non-alcoholic fatty liver disease
Abstract Non-alcoholic fatty liver disease (NAFLD) affects 25% of the adult population globally. Since liver fibrosis is the most important predictor of liver-related complications in patients with NAFLD, identification of patients with advanced fibrosis among at-risk individuals is an important iss...
Enregistré dans:
Auteurs principaux: | Katharine M. Irvine, Satomi Okano, Preya J. Patel, Leigh U. Horsfall, Suzanne Williams, Anthony Russell, Elizabeth E. Powell |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/3622a3451cc5424a98c6081d430e546b |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The emerging roles of ADAMTS-7 and ADAMTS-12 matrix metalloproteinases
par: Edward A Lin, et autres
Publié: (2009) -
Clinical significance of matrix metalloproteinase (MMP)-2 and MMP-9 expression in laryngeal squamous cell carcinoma
par: Rašić Dejan, et autres
Publié: (2021) -
Matrix metalloproteinase (MMP)-9 in cancer-associated fibroblasts (CAFs) is suppressed by omega-3 polyunsaturated fatty acids in vitro and in vivo.
par: Ayumi Taguchi, et autres
Publié: (2014) -
Usefulness of matrix metalloproteinase-7 in saliva as a diagnostic biomarker for laryngopharyngeal reflux disease
par: Nu-Ri Im, et autres
Publié: (2021) -
Matrix metalloproteinase MMP-8, TIMP-1 and MMP-8/TIMP-1 ratio in plasma in methicillin-sensitive Staphylococcus aureus bacteremia.
par: Erik Forsblom, et autres
Publié: (2021)